Vicki Chandler
Family Medicine · Memphis, TNNPI 1982617221
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,252, 4.2 times the $297 reported in 2023.
Across 118 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$461
- AbbVie$371
- Axsome Therapeutics, Inc.$345
- Neurocrine Biosciences, Inc.$261
- Alkermes, Inc.$233
- Vanda Pharmaceuticals Inc.$157
- plus $640 from 13 others
What the payments were for
- Food & beverage$2,467100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $461 |
| AbbVie | 13 | $371 |
| Axsome Therapeutics, Inc. | 18 | $345 |
| Neurocrine Biosciences, Inc. | 11 | $261 |
| Alkermes, Inc. | 11 | $233 |
| Vanda Pharmaceuticals Inc. | 8 | $157 |
| Johnson & Johnson | 6 | $111 |
| Lundbeck LLC | 5 | $103 |
| Ironshore Pharmaceuticals Inc. | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| Bausch Health US, LLC | 2 | $45 |
| Tris Pharma Inc | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Merck | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Corium, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$110
How this compares
$2,467 in reported general payments places this provider in the 70th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 19 | $384 |
| Quetiapine Fumarate | 26 | $341 |
| Lamotrigine | 14 | $217 |
| Hydroxyzine Hcl | 11 | $170 |
| Alprazolam | 24 | $153 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Memphis
- Michael WallaceMemphis$16K
- Jay SmithMemphis$14K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.